Changes in morphometric parameters of rat splenic lymphocytes under experimental streptozotocin-induced diabetes mellitus and its correction Зміни морфометричних показників лімфоцитів селезінки щурів в умовах експериментального стрептозотоцинового цукрового діабету та його корекції

Ханенко, О.Б and Попович, Ю.І. (2026) Changes in morphometric parameters of rat splenic lymphocytes under experimental streptozotocin-induced diabetes mellitus and its correction Зміни морфометричних показників лімфоцитів селезінки щурів в умовах експериментального стрептозотоцинового цукрового діабету та його корекції. Морфологія=Morphologia, 20 (1). p. 54. ISSN 1997-9665

Text Зміни морфометричних показників...pdf Download (267kB)

Abstract

Diabetes is a complex disease that affects various organs of the body, including the immune system. The aim of the study was to determine the features of morphometric changes in splenic lymphocytes in experimental streptozotocininduced diabetes mellitus and under conditions of correction with insulin and dapagliflozin. Methods. In a study of 35 rats with modeled streptozotocin-induced diabetes, morphometric and cluster analyses of splenic cells were performed following correction with insulin and dapagliflozin. Using the K-means method, three statistically significant cell populations were identified, differentiated by dimensional parameters and the nucleocytoplasmic ratio. Results. This study examined the morphometric changes of splenic lymphocytes under experimental diabetes mellitus induced by streptozotocin, as well as its correction using insulin and dapagliflozin. Male rats were divided into groups: control, diabetes, monotherapy with insulin, and combination therapy with insulin and dapagliflozin. Spleen samples were collected on the 42nd and 56th days of the experiment. Histological sections were analyzed using morphometric methods. Cluster analysis was performed based on cell and nuclear profile area, roundness, and the major and minor diameters. Three clusters representing different morphological profiles were identified. In the control group, small cells (Cluster 0) predominated, while in rats with diabetes, the proportion of medium and large lymphocytes (Clusters 1 and 2) increased. With insulin monotherapy, the content of small cells partially recovered, and this effect was more pronounced with combination therapy using dapagliflozin. On day 56, Cluster 0 cells still predominated in the control group, while the diabetes group showed marked progression of pathological changes. Conclusion. The combination of dapagliflozin and insulin effectively reduces morphological changes in splenic cells.

Item Type:	Article
Additional Information:	DOI: https://doi.org/10.26641/1997-9665.2026.1.54-66 https://sites.google.com/dmu.edu.ua/morphology/pro-zurnal/arhiv-nomeriv/2026-vol-20-1
Uncontrolled Keywords:	морфометрія, лімфоцити, селезінка, цукровий діабет, стрептозотоцин, інсулін, дапагліфлозин= morphometry, lymphocytes, spleen, diabetes mellitus, streptozotocin, insulin, dapagliflozin.
Subjects:	Diabetes Experimental medicine Morphology
Divisions:	University periodicals > Morphology
Depositing User:	Аліна Чеботарьова
Date Deposited:	31 Jul 2026 11:40
Last Modified:	31 Jul 2026 12:47
URI:	http://repo.dma.dp.ua/id/eprint/10193

Actions (login required)

View Item